Steven Cohen's EWTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 117,262 shares of Edgewise Therapeutics, Inc. (EWTX) worth $4.76 M, representing 0.01% of the portfolio. First purchased in 2023-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Steven Cohen has maintained this position in EWTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2023, adding 501,256 shares. Largest reduction occurred in Q1 2024, reducing 501,256 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Edgewise Therapeutics (EWTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edgewise Therapeutics (EWTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +117,262 | New Buy | 117,262 | $40.63 |
| Q1 2025 | -106,562 | Sold Out | 0 | $0.00 |
| Q4 2024 | +106,562 | New Buy | 106,562 | $26.70 |
| Q1 2024 | -501,256 | Sold Out | 0 | $0.00 |
| Q4 2023 | +501,256 | New Buy | 501,256 | $10.94 |
| Q3 2023 | -107,100 | Sold Out | 0 | $0.00 |
| Q2 2023 | +107,100 | New Buy | 107,100 | $7.75 |
Steven Cohen's Edgewise Therapeutics Investment FAQs
Steven Cohen first purchased Edgewise Therapeutics, Inc. (EWTX) in Q2 2023, acquiring 107,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Edgewise Therapeutics, Inc. (EWTX) for 7 quarters since Q2 2023.
Steven Cohen's largest addition to Edgewise Therapeutics, Inc. (EWTX) was in Q4 2023, adding 501,256 shares worth $5.48 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 117,262 shares of Edgewise Therapeutics, Inc. (EWTX), valued at approximately $4.76 M.
As of the Q2 2026 filing, Edgewise Therapeutics, Inc. (EWTX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Edgewise Therapeutics, Inc. (EWTX) was 501,256 shares, as reported at the end of Q4 2023.